The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

被引:202
|
作者
Cheng, KY
Lowe, ED
Sinclair, J
Nigg, EA
Johnson, LN
机构
[1] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England
[2] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany
来源
EMBO JOURNAL | 2003年 / 22卷 / 21期
关键词
cell cycle control; Plk1; polo box domain; phospho-peptide recognition; protein structure;
D O I
10.1093/emboj/cdg558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human polo-like kinase Plk1 localizes to the centrosomes, kinetochores and central spindle structures during mitosis. It plays an essential role in promoting mitosis and cytokinesis through phosphorylation of a number of different substrates. Kinase activity is regulated by a conserved C-terminal domain, termed the polo box domain (PBD), which acts both as an autoinhibitory domain and as a subcellular localization domain. We have determined the crystal structure of Plk1 PBD (residues 367-603) to 2.2 Angstrom resolution and the structure of a phospho-peptide-PBD (residues 345-603) complex to 2.3 Angstrom resolution. The two polo boxes of the PBD exhibit identical folds based on a six-stranded beta-sheet and an alpha-helix, despite only 12% sequence identity. The phospho-peptide binds at a site between the two polo boxes. It makes a short antiparallel beta-sheet connection and critical contacts to residues Trp414, Leu490, His538 and Lys540. Most of these residues had been shown to be important for biological activity through mutational studies. The results provide an explanation for phospho-peptide recognition and create the basis for new functional studies.
引用
收藏
页码:5757 / 5768
页数:12
相关论文
共 50 条
  • [21] A New Class of Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1
    Ahn, Mija
    Han, Young-Hyun
    Park, Jung-Eun
    Kim, Sungmin
    Lee, Woo Cheol
    Lee, Soo Jae
    Gunasekaran, Pethaiah
    Cheong, Chaejoon
    Shin, Song Yub, Sr.
    Kim, Hye-Yeon
    Ryu, Eun Kyung
    Murugan, Ravichandran N.
    Kim, Nam-Hyung
    Bang, Jeong Kyu
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 294 - 304
  • [22] Development of an anticancer agent targeting polo-box domain of polo-like kinase 1
    Ryu, E. K.
    Yim, M. S.
    FEBS JOURNAL, 2014, 281 : 113 - 113
  • [23] Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1
    Li, Zhiyan
    Zhang, Zhenguo
    Sun, Huiyong
    Xu, Lili
    Jiang, Cheng
    BIOORGANIC CHEMISTRY, 2019, 91
  • [24] Cyclic Peptomers as Targeting the Polo-Box Domain of Polo-Like kinase1
    Bang, Jeong Kyu
    Murugan, Ravichandran N.
    Park, Jae Hoon
    Lee, Kyung S.
    BIOPOLYMERS, 2011, 96 (04) : 466 - 466
  • [25] MEDI 337-Targeting the Polo Box Domain of Polo-like kinase 1 for therapeutics
    Carter, Karen M.
    Wipf, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [26] Polo-like kinase-1 in DNA damage response
    Hyun, Sun-Yi
    Hwan, Hyo-In
    Jang, Young-Joo
    BMB REPORTS, 2014, 47 (05) : 249 - 255
  • [27] Getting in and out of mitosis with Polo-like kinase-1
    Marcel A T M van Vugt
    René H Medema
    Oncogene, 2005, 24 : 2844 - 2859
  • [28] Getting in and out of mitosis with Polo-like kinase-1
    van Vugt, MATM
    Medema, RH
    ONCOGENE, 2005, 24 (17) : 2844 - 2859
  • [29] Identification of novel and selective non-peptide inhibitors targeting the polo-box domain of polo-like kinase 1
    Chen, Yanhong
    Yu, Zhiyan
    Liu, Yu
    Lin, Tongyuan
    Sun, Huiyong
    Yang, Dasong
    Jiang, Cheng
    BIOORGANIC CHEMISTRY, 2018, 81 : 278 - 288
  • [30] Thymoquinone and Poloxin are slow-irreversible inhibitors to human Polo-like kinase 1 Polo-box domain
    Peter H. Rehse
    Journal of Medical Colleges of PLA, 2010, (03) : 136 - 142